Ilaris and Uveitis

People who have certain conditions that cause inflammation throughout the body may benefit from Ilaris® (canakinumab). This medication is available by prescription and is specifically approved to treat a group of rare genetic conditions called cryopyrin-associated periodic syndromes (CAPS). It is also approved for systemic juvenile idiopathic arthritis (SJIA).
People with CAPS have an inherited mutation in a gene that causes an autoinflammatory response. This means the immune system attacks the body's own tissues, leading to inflammation. The inflammation then causes symptoms of the disease. Symptoms of CAPS can include but are not limited to:
  • Eye inflammation, such as:
    • Conjunctivitis (swelling of the membrane lining the eyelids or conjunctiva)
    • Uveitis (swelling of the uvea, the middle layer of the eye)
(For more details on this drug, click Ilaris Uses. This resource describes the specific uses for this medicine, explains how it works, and discusses whether it is safe for use in children.)
Diabetes Tips for Seniors
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.